vs

Side-by-side financial comparison of COASTAL FINANCIAL CORP (CCB) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.

Nutex Health, Inc. is the larger business by last-quarter revenue ($151.7M vs $138.0M, roughly 1.1× COASTAL FINANCIAL CORP). On growth, COASTAL FINANCIAL CORP posted the faster year-over-year revenue change (-5.8% vs -41.1%). COASTAL FINANCIAL CORP produced more free cash flow last quarter ($246.1M vs $69.0M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs -3.6%).

Fidelity National Financial, Inc., is an American provider of title insurance and settlement services to the real estate and mortgage industries. A Fortune 500 company, Fidelity National Financial generated approximately $8.469 billion in annual revenue in 2019 from its title and real estate-related operations. The company was the first instance of an attorney licensed by a Native American Tribe being certified as "authorized house counsel" in the state of Florida.

Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.

CCB vs NUTX — Head-to-Head

Bigger by revenue
NUTX
NUTX
1.1× larger
NUTX
$151.7M
$138.0M
CCB
Growing faster (revenue YoY)
CCB
CCB
+35.4% gap
CCB
-5.8%
-41.1%
NUTX
More free cash flow
CCB
CCB
$177.2M more FCF
CCB
$246.1M
$69.0M
NUTX
Faster 2-yr revenue CAGR
NUTX
NUTX
Annualised
NUTX
50.0%
-3.6%
CCB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCB
CCB
NUTX
NUTX
Revenue
$138.0M
$151.7M
Net Profit
$11.8M
Gross Margin
30.4%
Operating Margin
12.4%
20.4%
Net Margin
7.8%
Revenue YoY
-5.8%
-41.1%
Net Profit YoY
-80.8%
EPS (diluted)
$0.84
$2.34

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCB
CCB
NUTX
NUTX
Q4 25
$138.0M
$151.7M
Q3 25
$144.7M
$267.8M
Q2 25
$119.4M
$244.0M
Q1 25
$139.5M
$211.8M
Q4 24
$146.5M
$257.6M
Q3 24
$151.1M
$78.8M
Q2 24
$135.3M
$76.1M
Q1 24
$148.4M
$67.5M
Net Profit
CCB
CCB
NUTX
NUTX
Q4 25
$11.8M
Q3 25
$13.6M
$55.4M
Q2 25
$11.0M
$-17.7M
Q1 25
$9.7M
$21.2M
Q4 24
$61.6M
Q3 24
$13.5M
$-8.8M
Q2 24
$11.6M
$-364.0K
Q1 24
$6.8M
$-364.0K
Gross Margin
CCB
CCB
NUTX
NUTX
Q4 25
30.4%
Q3 25
57.8%
Q2 25
51.2%
Q1 25
55.9%
Q4 24
55.0%
Q3 24
27.8%
Q2 24
29.7%
Q1 24
15.1%
Operating Margin
CCB
CCB
NUTX
NUTX
Q4 25
12.4%
20.4%
Q3 25
12.4%
48.7%
Q2 25
12.0%
13.8%
Q1 25
8.4%
38.1%
Q4 24
11.7%
44.4%
Q3 24
10.8%
12.3%
Q2 24
11.1%
7.0%
Q1 24
5.9%
2.1%
Net Margin
CCB
CCB
NUTX
NUTX
Q4 25
7.8%
Q3 25
9.4%
20.7%
Q2 25
9.2%
-7.3%
Q1 25
7.0%
10.0%
Q4 24
23.9%
Q3 24
8.9%
-11.2%
Q2 24
8.6%
-0.5%
Q1 24
4.6%
-0.5%
EPS (diluted)
CCB
CCB
NUTX
NUTX
Q4 25
$0.84
$2.34
Q3 25
$0.88
$7.76
Q2 25
$0.71
$-2.95
Q1 25
$0.63
$3.33
Q4 24
$0.95
$11.56
Q3 24
$0.97
$-1.72
Q2 24
$0.84
$-0.07
Q1 24
$0.50
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCB
CCB
NUTX
NUTX
Cash + ST InvestmentsLiquidity on hand
$185.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$491.0M
$329.4M
Total Assets
$4.7B
$918.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCB
CCB
NUTX
NUTX
Q4 25
$185.6M
Q3 25
$166.0M
Q2 25
$96.7M
Q1 25
$84.7M
Q4 24
$40.6M
Q3 24
$46.9M
Q2 24
$40.8M
Q1 24
$30.0M
Stockholders' Equity
CCB
CCB
NUTX
NUTX
Q4 25
$491.0M
$329.4M
Q3 25
$475.3M
$317.2M
Q2 25
$461.7M
$235.3M
Q1 25
$449.9M
$176.9M
Q4 24
$438.7M
$132.4M
Q3 24
$331.9M
$60.4M
Q2 24
$316.7M
$62.7M
Q1 24
$303.7M
$63.0M
Total Assets
CCB
CCB
NUTX
NUTX
Q4 25
$4.7B
$918.5M
Q3 25
$4.6B
$964.5M
Q2 25
$4.5B
$841.0M
Q1 25
$4.3B
$761.9M
Q4 24
$4.1B
$655.3M
Q3 24
$4.1B
$438.5M
Q2 24
$4.0B
$422.4M
Q1 24
$3.9B
$404.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCB
CCB
NUTX
NUTX
Operating Cash FlowLast quarter
$254.6M
$70.4M
Free Cash FlowOCF − Capex
$246.1M
$69.0M
FCF MarginFCF / Revenue
178.3%
45.5%
Capex IntensityCapex / Revenue
6.1%
0.9%
Cash ConversionOCF / Net Profit
5.95×
TTM Free Cash FlowTrailing 4 quarters
$436.4M
$245.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCB
CCB
NUTX
NUTX
Q4 25
$254.6M
$70.4M
Q3 25
$59.0M
$99.5M
Q2 25
$66.0M
$27.3M
Q1 25
$71.7M
$51.0M
Q4 24
$259.8M
$54.0K
Q3 24
$62.6M
$6.8M
Q2 24
$72.1M
$13.3M
Q1 24
$56.8M
$3.1M
Free Cash Flow
CCB
CCB
NUTX
NUTX
Q4 25
$246.1M
$69.0M
Q3 25
$57.4M
$99.2M
Q2 25
$64.0M
$26.5M
Q1 25
$68.9M
$50.9M
Q4 24
$249.9M
$-341.0K
Q3 24
$60.2M
$6.2M
Q2 24
$69.5M
$12.7M
Q1 24
$55.0M
$2.3M
FCF Margin
CCB
CCB
NUTX
NUTX
Q4 25
178.3%
45.5%
Q3 25
39.7%
37.0%
Q2 25
53.6%
10.9%
Q1 25
49.4%
24.0%
Q4 24
170.6%
-0.1%
Q3 24
39.8%
7.8%
Q2 24
51.3%
16.7%
Q1 24
37.1%
3.4%
Capex Intensity
CCB
CCB
NUTX
NUTX
Q4 25
6.1%
0.9%
Q3 25
1.2%
0.1%
Q2 25
1.7%
0.3%
Q1 25
2.0%
0.0%
Q4 24
6.8%
0.2%
Q3 24
1.6%
0.8%
Q2 24
1.9%
0.7%
Q1 24
1.2%
1.1%
Cash Conversion
CCB
CCB
NUTX
NUTX
Q4 25
5.95×
Q3 25
4.34×
1.80×
Q2 25
5.99×
Q1 25
7.37×
2.40×
Q4 24
0.00×
Q3 24
4.65×
Q2 24
6.22×
Q1 24
8.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCB
CCB

Other$74.7M54%
Baa S Credit Enhancements$47.3M34%
Baa S Program Income$8.4M6%
Transaction Fees$4.9M4%
Servicing And Other Baa S Fees$1.6M1%
Baa S Fraud Enhancements$1.1M1%

NUTX
NUTX

Hospital Division$143.7M95%
Population Health Management Division$8.0M5%

Related Comparisons